News

A recent study has shown that genes overexpressed in diseases of the central nervous system were under-expressed in cancer (lung, colon and prostate) and vice versa.

Feeding pregnant female mice a diet high in fat derived from common corn oil resulted in genetic changes that substantially increased breast cancer susceptibility in three generations of female offspring.

Charting the genomic landscape of T-lineage acute lymphoblastic leukemia patients revealed insights that will guide research and help to lay the foundation for more targeted therapy.

Series D raises $12.2 million for the expansion of global exposure and company growth.

Scientists have taken an important step toward safer gene-editing cures for life-threatening disorders, from cancer to HIV to Huntington’s disease, by developing a technique that can spot CRISPR's mistakes.

St. Jude Children’s Research Hospital discovery of the mechanism of T cell exhaustion will lead to treatments to enhance immunotherapies against cancers and such viruses as HIV

Horizon Discovery announces inclusion of its Reference Standards in successful FDA approval of an oncology companion diagnostic test with leading next generation sequencing company.

Based on a new molecular study of tissues biopsied from various parts of the upper digestive tract, researchers have identified subtle, differences in gene mutations that could help in developing more tailored treatment options for cancer patients.

By exploiting this primordial system, RNA can be engineered to have the desired properties of a virus without engaging our more modern and, in this case, unwelcomed immune response.

Fragments snipped from tRNAs protect embryonic stem cells while they’re being epigenetically reprogrammed.